30 results
IP Health Blog
FDA Draft Guidance on Evaluation of Therapeutic Equivalence FDA Draft Guidance on Evaluation of Therapeutic Equivalence
August 4, 2022
Event
Frameworks for US Pharma Patent Disputes Frameworks for US Pharma Patent Disputes
June 30, 2022
Webinar
Federal Circuit IP Blog
Federal Circuit Sidesteps Determination of Generics’ Skinny Label as Protection Against Induced Infringement Federal Circuit Sidesteps Determination of Generics’ Skinny Label as Protection Against Induced Infringement
February 23, 2022
Articles
China’s “Hatch-Waxman” System: A Comparative Overview China’s “Hatch-Waxman” System: A Comparative Overview
September 8, 2021
WestlawArticles
Comparative Overview of Drug Patent Linkage Systems in China and the United States Comparative Overview of Drug Patent Linkage Systems in China and the United States
May 4, 2021
Westlaw TodayPodcasts
Life Sciences Podcast Series - Trademarks Life Sciences Podcast Series - Trademarks
March 12, 2021
1 result
Commentary
Rush for Generic Go-Ahead on Novel Drugs Roils Pharma Industry Rush for Generic Go-Ahead on Novel Drugs Roils Pharma Industry
June 19, 2020
Bloomberg LawDue to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.